Edition:
India

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

26.22USD
22 Jun 2018
Change (% chg)

$0.30 (+1.16%)
Prev Close
$25.92
Open
$25.97
Day's High
$27.80
Day's Low
$25.21
Volume
234,010
Avg. Vol
106,243
52-wk High
$33.86
52-wk Low
$8.10

Chart for

About

Akcea Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. The Company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense... (more)

Overall

Beta: --
Market Cap(Mil.): $1,860.50
Shares Outstanding(Mil.): 66.54
Dividend: --
Yield (%): --

Financials

  AKCA.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -4.36 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.08

BRIEF-Akcea Posts Q4 Loss Per Share $0.35

* AKCEA REPORTS FINANCIAL RESULTS AND HIGHLIGHTS FOR FOURTH QUARTER AND YEAR END 2017

27 Feb 2018

BRIEF-Akcea Completes Enrollment In Phase 2B Study Of Akcea-Apo(A)-LRx

* AKCEA COMPLETES ENROLLMENT IN PHASE 2B STUDY OF AKCEA-APO(A)-LRX Source text for Eikon: Further company coverage:

07 Feb 2018

Earnings vs. Estimates